Biliary and pancreatic lithotripsy devices by Watson, R. R. et al.
Journal Articles Donald and Barbara Zucker School of MedicineAcademic Works
2018






See next page for additional authors
Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Gastroenterology Commons
This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.
Recommended Citation
Watson RR, Parsi MA, Aslanian HR, Goodman AJ, Lichtenstein DR, Melson J, Navaneethan U, Pannala R, Trindade AJ, Maple JT, .
Biliary and pancreatic lithotripsy devices. . 2018 Jan 01; 3(11):Article 4487 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/4487. Free full text article.
Authors
R. R. Watson, M. A. Parsi, H. R. Aslanian, A. J. Goodman, D. R. Lichtenstein, J. Melson, U. Navaneethan, R.
Pannala, A. J. Trindade, J. T. Maple, and +4 additional authors
This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/4487
TECHNOLOGY STATUS EVALUATION REPORT
Biliary and pancreatic lithotripsy devices
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Background and Aims: Lithotripsy is a procedure for fragmentation or destruction of stones to facilitate their
removal or passage from the biliary or pancreatic ducts. Although most stones may be removed endoscopically
using conventional techniques such as endoscopic sphincterotomy in combination with balloon or basket extrac-
tion, lithotripsy may be required for clearance of large, impacted, or irregularly shaped stones. Several modalities
have been described, including intracorporeal techniques such as mechanical lithotripsy (ML), electrohydraulic
lithotripsy (EHL), and laser lithotripsy, as well as extracorporeal shock-wave lithotripsy (ESWL).
Methods: In this document, we review devices and methods for biliary and pancreatic lithotripsy and the evi-
dence regarding efﬁcacy, safety, and ﬁnancial considerations.
Results: Although many difﬁcult stones can be safely removed using ML, endoscopic papillary balloon dilation
(EPBD) has emerged as an alternative that may lessen the need for ML and also reduce the rate of adverse events.
EHL and laser lithotripsy are effective at ductal clearance when conventional techniques are unsuccessful, although
they usually require direct visualization of the stone by the use of cholangiopancreatoscopy and are often limited
to referral centers. ESWL is effective but often requires coordination with urologists and the placement of stents or
drains with subsequent procedures for extracting stone fragments and, thus, may be associated with increased costs.
Conclusions: Several lithotripsy techniques have been described that vary with respect to ease of use, general-
izability, and cost. Overall, lithotripsy is a safe and effective treatment for difﬁcult biliary and pancreatic duct
stones. (Gastrointest Endosc 2018;3:329-38.)
The American Society for Gastrointestinal Endoscopy
(ASGE) Technology Committee provides reviews of existing,
new, or emerging endoscopic technologies that have an
impact on the practice of GI endoscopy. Evidence-based
methods are used, with a MEDLINE literature search to
identify pertinent clinical studies on the topic and a search
of the MAUDE (Manufacturer and User Facility Device
Experience) database (U.S. Food & Drug Administration,
Center for Devices and Radiological Health) to identify
the reported adverse events of a given technology. Both
are supplemented by accessing the “related articles” feature
of PubMed and by scrutinizing pertinent references cited by
the identiﬁed studies. Controlled clinical trials are empha-
sized, but in many cases data from randomized controlled
trials are lacking. In such cases, large case series,
preliminary clinical studies, and expert opinions
are used. Technical data are gathered from traditional
and Web-based publications, proprietary publications,
and informal communications with pertinent vendors.
Technology Status Evaluation Reports are drafted
by 1 or 2 members of the ASGE Technology Committee,
reviewed and edited by the Committee, and approved
by the Governing Board of the ASGE. When ﬁnancial
guidance is indicated, the most recent coding
data and list prices at the time of publication are pro-
vided. For this review the MEDLINE database was
searched through February 2017 for articles related to
biliary and pancreatic lithotripsy by using relevant
This document was reviewed and approved by the Governing Board of the American Society for Gastrointestinal
Endoscopy (ASGE).
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keywords including ‘‘lithotripsy,’’ ‘‘mechanical,’’ ‘‘elec-
trohydraulic,’’ ‘‘laser,’’ and ‘‘shock wave’’ as well as
‘‘bile duct,’’ ‘‘choledochus,’’ ‘‘gallstone,’’ ‘‘gallbladder,’’
‘‘pancreas,’’ ‘‘choledochoscope,’’ ‘‘cholangioscope,’’
and ‘‘pancreatoscope.’’
Technology Status Evaluation Reports are scientiﬁc re-
views provided solely for educational and informational
purposes. Technology Status Evaluation Reports are not
rules and should not be construed as establishing a legal
standard of care or as encouraging, advocating,
requiring, or discouraging any particular treatment or
payment for such treatment.
BACKGROUND
Lithotripsy is a procedure for the destruction or frag-
mentation of stones to facilitate their removal or passage
from the biliary or pancreatic ducts. Lithotripsy may be
performed by intracorporeal approaches using mechani-
cal, electrohydraulic, or laser devices at the time of endo-
scopic (via ERCP) or percutaneous access, or by
extracorporeal shock wave lithotripsy (ESWL). This docu-
ment will review devices and methods for biliary and
pancreatic lithotripsy and is an update of a previously




A mechanical lithotripter consists of a wire basket, a
metal sheath, and a handle that provides mechanical
retraction of the basket into the metal sheath, thereby
directing a crushing force to stones captured within the
basket. There are 2 basic designs of mechanical lithotrip-
ters. Integrated devices incorporate all components of
the system and are designed for use through the operating
channel of the duodenoscope (Fig. 1). Salvage devices
consist of only the metal sheath and handle and are
typically used when a non–lithotripsy-compatible basket
containing a stone becomes impacted in the bile or
pancreatic duct during attempted stone extraction (Fig. 2).
Integrated lithotripters function like a standard stone
basket until lithotripsy is required. They can be used on
stones anywhere within the ducts and can be used multiple
times during the same procedure. Both single-use and
reusable systems are available in a variety of basket sizes.
Wire-guided baskets are available. Some units require
assembly before use.
Salvage devices are designed to be applied over a variety
of stone-removal baskets, but not all baskets are lithotripter-
compatible. Basket designs ideally include failure points that
break in a manner that allows basket disimpaction from
around the stone when an application of maximum force
fails to achieve stone fragmentation. The use of a salvage lith-
otripter with a noncompatible basket may result in wire frac-
ture at an unpredictable site along the length of the device,
possibly away from the actual basket. When salvage litho-
tripsy is required, the basket handle is cut off, and the plastic
catheter covering the wires is removed. The metal litho-
tripter sheath is then advanced over the wires of the
impacted basket to the level of the stone, and the lithotripsy
handle is attached to the metal sheath and the basket wires.
Under ﬂuoroscopic guidance, rotation of the handle retracts
the basket and the stone against the sheath, breaking the
stone or the basket and allowing the basket to be removed.
Some models can be advanced through the endoscope,
whereas others require removal of the endoscope before
positioning of the metal sheath. Speciﬁcations of commer-
cially available integrated lithotripters and salvage mechani-
cal lithotripters are given in Table 1.
Electrohydraulic lithotripsy
Electrohydraulic lithotripsy (EHL) systems consist of a
bipolar probe and a charge generator. When a charge is
transmitted across the electrodes at the tip of the probe,
a spark is created. This induces expansion of the sur-
rounding ﬂuid, resulting in an oscillating shock wave of
pressure that is typically adequate to fragment most
stones. Saline solution irrigation is required to provide a
medium for shock wave transmission, to assure visualiza-
tion, and to ﬂush away debris. The procedure is usually
Figure 1. Example of an integrated mechanical lithotripter basket with a
plastic inner sheath and metal outer sheath (A) and handle (B). (Used
with permission from Olympus.)
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performed under direct cholangioscopic or pancreato-
scopic guidance to avoid errant application of shock
waves that may potentially cause ductal trauma and perfo-
ration. However, lithotripsy probes have been used with
ﬂuoroscopic guidance only, facilitated by balloons or bas-
ket catheters that center the probe. The probe is directed
at the stone and is optimally advanced 5 mm from the tip
of the endoscope and positioned 1 to 2 mm from the
stone.2 EHL is activated by a foot pedal. Stone fragments
are then removed by standard means.3 EHL destruction of
a biliary stone under cholangioscopic guidance is
demonstrated in Video 1 (available online at www.
VideoGIE.org).
The Autolith and newer Autolith Touch EHL units
(Nortech; Northgate Technologies Inc, Elgin, Ill, USA)
are the only EHL systems that have received clearance
by the U.S. Food & Drug Administration (FDA) for biliary
stones. The Autolith Touch system allows selection
between low-, medium-, and high-power settings and
the number of pulses delivered by a single foot pedal acti-
vation. The manufacturer recommends beginning at low
power and suggests that 3 to 5 pulses per activation is
ideal for most procedures. The legacy Autolith system al-
lows titration of power (10% to 100%), shot frequency (1/
sec to 30/sec), and number of shots delivered by a single
foot pedal activation (1 to 60). The manufacturer recom-
mends beginning with 30% to 40% power and 3 to 5 shots
delivered per foot pedal activation. Lower shot fre-
quencies may sufﬁce for impacted stones, whereas fewer
shots at a higher shot frequency are suggested for freely
mobile stones. Pancreatic lithotripsy is a common off-
label use for these EHL systems. Anecdotally, higher-
power settings are needed for fragmentation of pancre-
atic stones. The Nortech bipolar biliary EHL probe is
1.9F (0.66 mm) and is available in 250-cm and 375-cm
lengths. The probes are single-use items; using higher-
power settings and a higher number of shots may reduce
probe life. Complete destruction of large or multiple
stones may therefore require more than 1 probe during
the same session.
Laser lithotripsy
Several laser lithotripsy systems have beenused for biliary
and pancreatic applications. Focusing laser light of a high-
power density on the surface of a stone creates a plasma
composed of a gaseous collection of ions and free electrons.
This plasma bubble oscillates and induces cavitation with
tensile and compressive waves that fracture the stone sur-
face. Fragmentation of a large bile duct stone using laser lith-
otripsy under cholangioscopic guidance is demonstrated in
Video 2 (available online at www.VideoGIE.org).
Holmium:yttrium aluminum garnet (YAG) lasers are
commercially available (Lumenis Inc, San Jose, Calif,
USA), are widely used for urinary tract stones, and have
FDA clearance for the treatment of gallbladder and bile
duct stones as well. The laser-light wavelength (2100 nm)
is in the near-infrared spectrum and delivers high-energy
pulses of about 500 to 1000 mJ.4 The single-use laser
delivery ﬁbers are up to 4 m long and are available in
multiple diameters; 550- or 1000-mm ﬁbers are used most
commonly for biliary applications. They ﬁt through the
working channels of most cholangioscopes and pancreato-
scopes. As with EHL, direct visualization of the stones is
generally recommended to prevent ductal trauma. How-
ever, stones have also been targeted by the use of
centering balloons with ﬂuoroscopic guidance alone.3,4
Power settings are usually 0.6 to 1.0 J at 6 to 10 Hz for total
laser energy of 12 kJ.5 These laser lithotripter units are
typically wheeled or placed on a wheeled cart, weigh 84
to 303 kg, and require 110 AC or 220-volt electricity,
depending on the wattage of the unit.
The frequency-doubled double-pulse neodymium:YAG
(FREDDY) laser is FDA cleared for bile duct stones. The
FREDDY laser uses wavelengths of 532 and 1064 nm and
generates up to 120 to 160 mJ (approximately 24 mJ at 532
nm). Laser-pulse duration is 1.2 ms at 160 mJ, with single
or dual pulse at adjustable rates of 1, 3, 5, or 10 Hz with stan-
dard 110-volt AC electricity, or 15 or 20Hzwith 220-volt elec-
tricity. However, the latter pulse frequencies are rarely
necessary. The manufacturer recommends initial settings
of 120 mJ single pulse and 3 to 5 Hz repetition rate, which
Figure 2. Salvage lithotripter consisting of (A) a metal sheath and (B) a handle. (Used with permission from Cook Medical.)
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can be increased to 160mJ and 10Hz. Double pulse at 120 or
160 mJ will cause the ﬁber to burn back into the buffer clad-
ding of the laser more readily than single-pulse settings. The
ﬁbers (ThinFlex200Rplus) are 3.5 m long, have an outer
diameter of 420 mm, and are marketed for reuse up to 10
times. These ﬁbers can be inserted through the ports of
most cholangioscopes and pancreatoscopes. The FREDDY
laser ﬁbers have also been used through the guidewire
port of a stone-extraction balloon to maintain its position
in the center of the duct.6,7 This laser is portable, is 250 
850 600 mm in size, and weighs 45 kg. The FREDDY laser
is marketed in the United States as the U100Plus (World of
Medicine, Orlando, Fla, USA).
Other lasers have been designed to limit duct injury by
recognizing the difference between stone and tissue, and
clinical outcomes with these systems have been reported
in retrospective series.5,8 However, these laser systems
are not currently marketed or sold in the United States.
Extracorporeal shock wave lithotripsy
Extracorporeal shock wave lithotripsy (ESWL) uses shock
waves generated outside the body by a lithotripter to frag-
ment stones within the body. ESWL was developed for the
treatment of urologic stones, and ESWL for biliary or pancre-
atic stones is thus often performed in collaboration with
urology colleagues. It has been theorized that the passage
of shock waves through the anterior and posterior surfaces
of the stone liberates compressive and tensile forces,
causing cavitation that leads to stone fragmentation.3,8 All
lithotripters have 3 components: a shock wave generator,
TABLE 1. Mechanical lithotripters
Design















Trapezoid RX M00510860 $933/$483 No Yes 3.2 Yes
(4 open basket
diameters,
1.5 - 3 cm)
M00510870 $933/$483 No Yes 3.2 Yes
M00510880 $933/$483 No Yes 3.2 Yes
M00510890 $933/$483 No Yes 3.2 Yes
Alliance IIy M00550620 $450 NA NA NA NA
Cook Endoscopy
Fusion FS-LXB-2X4 $419 No Yes 4.2 Yes
FS-LXB-3X6 $419 No Yes 4.2 Yes
Olympus America Corp
LithoCrushV BML-V242QR-30 $1531/$620 Yes Yes 4.2 Yes
BML-V232QR-30/26 $1531/$620 Yes Yes 3.2 Yes
BML-V442QQR-30
(wire-guided)
$1531/$620 Yes Yes 4.2 Yes
MAJ-441y $911 NA NA NA NA
Salvagez
Cook Endoscopy
Conquest TTT TTCL-1 (cable) $202 Yes Yes 3.2 No
TTCL-10 (cable) $202 Yes Yes 3.7 No
Soehendra SLC-2 (cable)y $202 Yes No Remove scope No
SLH-1y $368 NA NA NA NA
Olympus America Corp
BML-110A-1y,x $692 NA NA NA No
MAJ-403
(sheath alone)y
$114 Yes No Remove scope No
NA, Not applicable.
*Initial cost includes complete system for 1 use, with all reusable components and 1 basket. Per-use cost includes the cost for single use of a new disposable component and/or
basket.
yReusable.
zExclusive of the cost of the entrapped basket.
xIncludes both emergency sheath and handle.
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which produces and focuses the shock waves; a means of
coupling the shock wave to the patient; and an imaging
modality to target the stone (Fig. 3).9,10
Shock wave generators use electrohydraulic, piezoelec-
tric, or electromagnetic technology to generate shock
waves.11 Lithotripters have a focusing mechanism to
concentrate energy onto the stone and thus reduce any
damaging effects on the surrounding tissue.8,10 Externally
generated shock waves require transmission into the
patient by a medium. Initial platforms used water as the
medium, requiring the patient to be partially submerged
in a water basin. In newer systems, coupling is achieved
by the use of water-ﬁlled cushions brought into contact
with the skin using a gel.1,11
Accurate targeting of the shock waves on the stone is
essential for effective lithotripsy and is achieved by use
of an imaging modality.11-13 Fluoroscopy and US have
been used for this purpose. Because ﬂuoroscopy can
detect only radiopaque stones, an intraductal stent may
be placed to allow focusing of shock waves along the
duct to target additional radiolucent stones. US can detect
both radiopaque and radiolucent stones, but interposed
air-ﬁlled intestinal loops may hamper the detection of
pancreatic and distal biliary stones.
ESWL systems are available from multiple manufac-
turers. Some ESWL systems are FDA cleared for the treat-
ment of biliary stones. In clinical practice, these systems
are used much more frequently for pancreatic stones,
which is an off-label indication for all systems.
INDICATIONS
Intraductal lithotripsy is used for stones in the intrahe-
patic and extrahepatic bile ducts and for obstructing stones
in the pancreatic duct that cannot be removed by conven-
tional methods. ESWL is used for the same indications and
rarely as an adjunctive or primary therapy for gallbladder
stones.
EFFICACY AND COMPARATIVE STUDIES
Biliary lithotripsy
Several large case series have demonstrated that me-
chanical lithotripsy (ML) leads to complete bile duct clear-
ance in about 80% to 90% of patients; however, 20% to
30% of patients require more than 1 procedure.11,14-24
ML is less likely to be successful with larger and impacted
stones.21,24 In a series of 209 patients with a median stone
diameter of 18 mm, the rate of successful stone clearance
fell from 87.6% to 67.6% for stones >25 mm.21 Another
series of 116 patients found that the cumulative
probability of bile duct clearance for stones >28 mm was
68% compared with >90% for those <10 mm.24
Recently, the use of endoscopic papillary balloon dila-
tion (EPBD) has been shown to be an effective alternative
to ML for large bile duct stone removal. A meta-analysis
including 6 randomized controlled trials (RCTs) comparing
endoscopic sphincterotomy (ES) combined with conven-
tional techniques versus ES plus EPBD demonstrated that
the 2 approaches were equally effective for stone clear-
ance. However, EPBD was also associated with a signiﬁcant
reduction in the need for ML, particularly for stones
>15 mm (odds ratio, 0.15; 95% conﬁdence interval [CI],
0.03-0.68; PZ .01), and a signiﬁcantly lower rate of perfo-
ration.25 A second meta-analysis including 902 patients
from 7 RCTs similarly showed that ES plus EPBD was asso-
ciated with a reduced need for ML compared with ES alone
(15% versus 32%; RR Z 0.49 [CI, 0.32, 0.74]; P Z .0008)
and was also associated with a reduction in the overall rate
of adverse events (11% versus 18%; relative risk Z 0.58
[CI, 0.41, 0.81]; P Z .001).26
Case series of patients with bile duct stones refractory to
standard endoscopic therapy report stone fragmentation
and clearance in 77% to 100% using EHL.2,3,27-35 Repeated
procedures and/or other forms of lithotripsy may be
required. Laser lithotripsy has a potential advantage of rela-
tively precise targeting of stones that may reduce the risk
of injury to surrounding tissue.36 In several small series,
the holmium:YAG laser has been reported to result in
total clearance of intrahepatic and extrahepatic bile duct
stones in 85% to 100% of patients.6,7,37-54 Similar results
have been achieved with a variety of lasers that are
currently unavailable in the United States.3,5,7,55
Percutaneous approaches to EHL or laser lithotripsy
may be used for intrahepatic stones, with reported rates
of ductal clearance in 80% to 97% of patients.56-63 Howev-
er, multiple (3 to 6) procedures may be required, and high
rates of cholangitis and stone recurrence rates have been
reported, likely resulting from retained occult stone frag-
ments and intrahepatic strictures. As such, percutaneous
Figure 3. Example of an ESWL system including the generator and imag-
ing apparatus with a patient in position. ESWL, Extracorporeal shock-wave
lithotripsy. (Used with permission from Tailly GG. Extracorporeal shock
wave lithotripsy today. Indian Journal of Urology 2013;29:200-7.)
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drains are frequently left in place for several weeks in these
patients.
Studies using ESWL for clearance of bile duct stones
refractory to endoscopic treatment have reported a com-
plete stone clearance rate of 78% to 90%.30,64-68 More
than 1 ESWL session may be required to achieve adequate
stone fragmentation to allow complete ductal clearance.
ERCP is commonly performed after an ESWL session for
removal of stone fragments.65,68,69 Fragmentation of the
stones in response to ESWL and thus complete ductal
clearance may be inversely related to stone size.70
Obesity has been suggested as a risk factor for ESWL
failure and increased procedural adverse events, whereas
intravenous administration of cholecystokinin during
ESWL has been associated with a higher rate of complete
stone clearance.64,71,72 Recurrence of bile duct stones after
successful ESWL and ductal clearance has been reported in
14% to 23% of patients.73,74
ESWL is rarely performed for management of refractory
biliary stones in the United States, and most centers prefer
cholangioscopy-guided laser or EHL for this purpose.75
Two RCTs have compared ESWL with laser lithotripsy in
this setting. In 1 trial, 9 of 17 (52.4%) patients
undergoing ESWL achieved complete stone clearance
compared with 14 of 17 (82.4%, P Z .07) for those
undergoing laser lithotripsy.55 In another trial, rates of
stone clearance were 73% (22/30) and 97% (29/30) for
ESWL and laser, respectively (P < .05).76 In both trials,
the required number of treatment sessions was also
signiﬁcantly lower in favor of laser lithotripsy. However,
in another RCT, complete bile duct clearance was
observed in similar proportions of patients randomized
to EHL and ESWL, at 74% and 79%, respectively.30 In
these 3 RCTs, crossing over to the alternative form of
lithotripsy improved the overall clearance rates to 94% to
100%.30,55,76 In a retrospective case series of 108 patients
with failed biliary stone extraction using usual methods,
success was achieved with ML in 33 patients, with EHL in
65 patients, and with ESWL in 7 of 10 patients (all with
intrahepatic stones) for an overall success rate of 95%.31
ESWL has been used for fragmentation of gallbladder
stones, but due to high stone recurrence rates and the
minimal morbidity of laparoscopic cholecystectomy, this
method is rarely used.77
Pancreatic lithotripsy
Multiple case reports and case series describe the
successful management of pancreatic duct stones with
ML78,79 and EHL.29,79-84 Symptom improvement is seen
in the majority of patients with complete or partial
duct clearance.78-80 A multicenter retrospective study of
holmium:YAG laser lithotripsy of pancreatic stones in 28
patients demonstrated complete duct clearance in 79%,
with improvements in pain and reduction in use of
narcotics in 89% of patients.85 Other small series
describing laser lithotripsy for pancreatic stones have
reported similar outcomes.54,86,87
A meta-analysis of 27 studies (nZ 3189 patients) in the
use of ESWL for chronic calciﬁc pancreatitis reported a
pooled estimate for complete ductal clearance rate of
71% (95% CI, 69-72.4) and partial ductal clearance rate of
22% (95% CI, 20.5-24.3).76 Multiple sessions may be
required to achieve ductal clearance.88 This analysis also
reported a signiﬁcant improvement in quality of life,
degree of pain, and narcotic use after ESWL therapy.
Combining ESWL with ERCP may increase the rate of
complete ductal clearance,89 although in an RCT of 55
patients, the addition of ERCP to ESWL had no additive
beneﬁt in pain outcomes.90 In patients with obstructive
pancreatic duct stones, ESWL has shown efﬁcacy in
preventing recurrent attacks of acute pancreatitis.91 A
stone recurrence rate of 18% to 22% has been reported
after successful ESWL of pancreatic duct stones.88,89 There
are no randomized studies comparing the efﬁcacy of ESWL
with other lithotripsy modalities for pancreatic ductal
clearance.
EASE OF USE AND LIMITATIONS
Mechanical lithotripsy
For bile duct stones that prove refractory to removal
with standard methods, ML and EPBD are appropriate con-
siderations as a next step. Although ML is relatively straight-
forward to perform, some integrated lithotripters require
assembly and greater knowledge of their function. Both
integrated and salvage devices are stiff, are somewhat
unwieldy, and require more time to operate than standard
stone extraction devices.
EHL and laser lithotripsy
Available EHL generators are compact, easily mobile,
and require no special electricity or protective wear. The
holmium:YAG and FREDDY lasers are medium-sized,
portable units that may require 220 volt electrical power.
Personnel who use medical lasers need formal training in
laser function and safety. Special protective eyewear must
be used.92 Before endoscopy is started, some lasers must
be warmed up and calibrated. Both EHL and laser ﬁbers
may be difﬁcult to manipulate through the working
channel of a cholangioscope or a pancreatoscope
because of their size and fragility. Prolonged application
of energy and/or repeated procedures may be required
to achieve complete stone fragmentation and clearance
with either EHL or lasers.
EHL and laser lithotripsy are usually performed under
direct visualization by use of a cholangioscope or a
pancreatoscope passed through the duodenoscope. A
single-use cholangioscopy platform (SpyGlass DS; Boston
Scientiﬁc Corp, Natick, Mass, USA) allows for a single oper-
ator to control lithotripsy, whereas conventional “mother-
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daughter” cholangioscopes typically require 2 operators.
During lithotripsy, stone fragments frequently obscure
visualization, and continuous irrigation is required.2,5
Percutaneous transhepatic or T-tube access for cholangio-
scopy and antegrade application of EHL or laser lithotripsy
allow formore direct ductal access and can potentially be per-
formed with no sedation or lighter sedation. Disadvantages
include the need for establishing large-caliber percutaneous
access, logistical coordination with an interventional radiolo-
gist, and the requirement for a sterile ﬁeld.
ESWL
Most pancreaticobiliary ESWL procedures in the United
States are performed in collaborationwith urologists because
of their familiarity with the equipment and experience in
treating urinary tract stones.91 Adequate training has been
shown to improve the success rate of ESWL for urinary
stones among urologists93 and is suggested for
gastroenterologists who wish to perform pancreaticobiliary
ESWL procedures.94,95 Signiﬁcant variation exists in clinical
practice with regard to coordination of these procedures
with colleagues in urology and anesthesia.
Because most biliary stones are radiolucent, placement
of a biliary stent before ESWL is usually required to help
with ﬂuoroscopic stone localization.75 In patients with
obstructive pancreatic duct stones, a temporary
pancreatic stent may assist in localization, reduce the risk
of pancreatitis, and reduce the cumulative number of
shock waves required for stone fragmentation.91,96 After
ESWL, stone fragments may or may not require endoscopic
removal. Intravenous administration of secretin or chole-
cystokinin during ESWL may improve stone passage
through the pancreatic and bile ducts, respectively.72,97
SAFETY
The majority of adverse events related to intraductal litho-
tripsy are associated with gaining pancreaticobiliary access
(eg, ERCPor percutaneous transhepatic access) andwith chol-
angiopancreatoscopy and include pancreatitis, hemorrhage,
perforation, and sepsis.56-60 There are no speciﬁc contraindi-
cations to intraductal lithotripsy beyond those associated
with ERCP. Intraductal devicesmay be safely used sequentially
during a single procedure (eg, EHL followed by ML). Biliary
EHLand laser lithotripsy havebeenassociatedwith cholangitis
rates of up to 14%. Therefore, the use of prophylactic antibi-
otics should be considered, particularly in the setting of
anticipated incomplete biliary drainage or with immunosup-
pressed patients such as liver transplant recipients.98
Intraductal pancreatic lithotripsy has been associated with
mild pancreatitis rates of up to 7%.3,4,21,27 Additional rare
adverse events include hemobilia, ductal perforation, and
bile leak.3 The need for prolonged irrigation during EHL and
laser lithotripsy procedures may result in retrograde entry of
saline into the stomach in quantities sufﬁcient to pose a risk
for aspiration; as such, consideration should be given to
airway protection during these procedures. Basket
impaction is a potential adverse event unique to ML.
ESWL for cholelithiasis has a reported adverse event rate
of 30% to 40%.1 Petechial skin lesions and biliary colic
(related to passage of stone fragments) are common.95
Adverse events have been reported in 14% of patients
undergoing ESWL for choledocholithiasis, including
pain, hemobilia, cholangitis, sepsis, pancreatitis, and
hematuria.1,95 The type of lithotripter used may affect
the rate of adverse events.67
Adverse events associated with pancreatic ESWL
have been reported in 5% to 10% of patients.98,99 In a
meta-analysis of 27 studies, post-ESWL pancreatitis was
the most common adverse event, occurring in 4.2%
of patients.88 Other adverse events including cardiac
arrhythmias, infections, bleeding, cholangitis, abdominal
pain, pseudocyst formation, and perforation have been
reported.89,91,99,100 ESWL is contraindicated in pregnancy,
coagulation disorders, calciﬁed aortic aneurysms, and pres-
ence of lung tissue in the shock wave path.101
FINANCIAL CONSIDERATIONS
Mechanical lithotripters are relatively inexpensive
compared with other lithotripsy modalities (Table 1). The
Autolith Touch EHL generator (Northgate Technologies
Inc, Elgin, Ill, USA) has a list price of $17,900, and the
Micro II probes are $429 each. The P20 holmium:YAG
laser (Lumenis Inc, San Jose, Calif, USA) is priced at
$35,000, whereas ﬁbers cost $490. Laser units may be
available on a fee-per-use basis, with an additional charge
for ﬁber reprocessing. The costs of choledochoscopes
and repairs also need to be considered. Holmium:YAG
and FREDDY lasers are frequently used in urology and
may be a shared resource. ESWL lithotripters cost about
$450,000 to $800,000; many large medical centers own
them primarily for the treatment of urinary tract stones.
In smaller institutions or surgery centers, leasing or renting
of ESWL lithotripters is an option.
Endoscopic lithotripsy has a dedicated Current Proce-
dural Terminology (CPT) code: 43265 (ERCP with endo-
scopic retrograde destruction, lithotripsy of calculus/
calculi, any method). The CPT code for cholangioscopy/pan-
creatoscopy is 43273 (endoscopic cannulation of papilla
with direct visualization of pancreatic/common bile duct
[s]). This code is reportable in addition to the primary pro-
cedure code (eg, 43264 [ERCP with endoscopic removal of
calculus/calculi from biliary and/or pancreatic ducts]). If 2
endoscopists are involved, 1 endoscopist may code 43264
and the other may use the cholangioscopy/pancreatoscopy
and lithotripsy procedure code as outlined above. ESWL for
biliary or pancreatic stones may be coded as CPT 43265 with
a letter of explanation, or as CPT 47999 (unlisted procedure,
biliary tract), or as CPT 48999 (unlisted procedure,
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pancreas) with an annotation that it is similar to CPT 50590
(renal lithotripsy, extracorporeal shock wave). There is a
HCPCS (Healthcare Common Procedure Coding System)
code S9034 (ESWL for gallstones), but this is not accepted
by Medicare and many other providers.
The Centers for Medicare &Medicaid Services (CMS) has
implemented Comprehensive Ambulatory Payment Classiﬁ-
cations (C-APCs) wherein ERCP with lithotripsy may also be
coded under APC group 5331 (complex GI procedures). Un-
der the C-APC grouping, a single payment is provided for the
primary service, whereas all other services performed on the
same date are considered supportive to the delivery of the
primary service. The average CMS payment for ERCP with
lithotripsy using the C-APC 5331 group is $3941.
CONCLUSION
Lithotripsy is a relatively safe and effective treatment for
difﬁcult biliary and pancreatic stones.Many refractory stones
can be removed with widely available techniques such as
EPBD and/or ML. Other forms of lithotripsy are used less
frequently and are generally limited to referral centers.
EHL and laser lithotripsy usually require direct visualization
with cholangiopancreatoscopy. ESWL is effective but expen-
sive, often requires coordination with urologists and place-
ment of internal drains or stents, and may require
subsequent procedures for extraction of stone fragments.
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